The iconic rise of Viagra has firmly established as a example of pharmaceutical success, yet its future within the broader market now presents questions about potential yields . Alternative versions are undercutting patent protection , prompting anxieties that investing in companies closely tied to Viagra's previous position could be a dangerous st